Related content

Multidisciplinary approach to cancer treatment: a model for breast cancer treatment at the M.D. Anderson Cancer Center

By Kim Ryungsa   Toge Tetsuya  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 356-363

Springer Publishing Company

Access to resources Recommend Favorite

Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center

By Akyurek Serap   Chang Eric   Yu Tse-Kuan   Little Darrin   Allen Pamela   McCutcheon Ian   Mahajan Anita   Maor Moshe   Woo Shiao  

Journal of Neuro-Oncology, Vol. 80, Iss. 2, 2006-11 ,pp. : 177-183

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

By Cristofanilli M.   Holmes F.A.   Esparza L.   Valero V.   Buzdar A.U.   Neidhart J.A.   Hortobagyi G.N.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 225-233

Springer Publishing Company

Access to resources Recommend Favorite

Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?

By Shen Yu   Dong Wenli   Esteva Francisco   Kau Shu-Wan   Theriault Richard   Bevers Therese  

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 347-356

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma. Daliani DD, Assikis V, Tu SM, Papandreou CN, Pagliaro LC, Holtkamp T, Wang X, Thall PF, Logothetis CJ, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX - Cancer 2003;97:561-567

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 412-412

Elsevier

Access to resources Recommend Favorite